Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-24

Clinical Trial Update: An Evaluation of Interlaminar Lumbar Instrumented (ILIF™)

View source ↗

Summary

The document notes the completion of a clinical trial evaluating Interlaminar Lumbar Instrumented (ILIF) for degenerative disc disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Interlaminar Lumbar Instrumented (ILIF)

Snippet

Sponsor: NuVasive | Conditions: Degenerative Disc Disease | Status: COMPLETED